3627 results for «313»
3627 results
Integrating FFRangio into your daily practice - Empowering wire-free insights
18 May 2023 – From EuroPCR 2023
In this session, dive into the world of FFRangio, from concept to clinical reality, and then analyze different cases in real practice to see how useful the physiology is, to try to understand why it is still so little used, and to learn how FFRangio could...
Management of PCI complications
16 May 2023 – From EuroPCR 2023
Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.
Meaningful innovations in interventional cardiology
18 May 2023 – From EuroPCR 2023
In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!
Bubble trouble: aortic air embolization and de-embolization during coronary angiography
09 Aug 2021
Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.

Author
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial
29 Oct 2024
Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.

Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Author

Author